SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-006121
Filing Date
2019-04-10
Accepted
2019-04-10 17:21:37
Documents
44
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0219_oramedpharma.htm 10-Q 381784
2 CERTIFICATION f10q0219ex31-1_oramedpharma.htm EX-31.1 13298
3 CERTIFICATION f10q0219ex31-2_oramedpharma.htm EX-31.2 13951
4 CERTIFICATION f10q0219ex32-1_oramedpharma.htm EX-32.1 4986
5 CERTIFICATION f10q0219ex32-2_oramedpharma.htm EX-32.2 5875
6 GRAPHIC img_001.jpg GRAPHIC 1610
7 GRAPHIC img_002.jpg GRAPHIC 1288
8 GRAPHIC img_003.jpg GRAPHIC 1145
  Complete submission text file 0001213900-19-006121.txt   2458066

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE ormp-20190228.xml EX-101.INS 381652
10 XBRL SCHEMA FILE ormp-20190228.xsd EX-101.SCH 29470
11 XBRL CALCULATION FILE ormp-20190228_cal.xml EX-101.CAL 40194
12 XBRL DEFINITION FILE ormp-20190228_def.xml EX-101.DEF 120788
13 XBRL LABEL FILE ormp-20190228_lab.xml EX-101.LAB 245862
14 XBRL PRESENTATION FILE ormp-20190228_pre.xml EX-101.PRE 175649
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 19742309
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1